254 related articles for article (PubMed ID: 23846739)
21. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.
Tsou CL; Peters W; Si Y; Slaymaker S; Aslanian AM; Weisberg SP; Mack M; Charo IF
J Clin Invest; 2007 Apr; 117(4):902-9. PubMed ID: 17364026
[TBL] [Abstract][Full Text] [Related]
22. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
[TBL] [Abstract][Full Text] [Related]
23. CCL13 and human diseases.
Li L; Dai F; Wang L; Sun Y; Mei L; Ran Y; Ye F
Front Immunol; 2023; 14():1176639. PubMed ID: 37153575
[TBL] [Abstract][Full Text] [Related]
24. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
26. CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis.
Yamaguchi A; Nozawa K; Fujishiro M; Kawasaki M; Suzuki F; Takamori K; Ogawa H; Takasaki Y; Sekigawa I
Mod Rheumatol; 2013 Sep; 23(5):856-63. PubMed ID: 23007802
[TBL] [Abstract][Full Text] [Related]
27. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
28. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ
Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301
[TBL] [Abstract][Full Text] [Related]
29. Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.
Owen JL; Criscitiello MF; Libreros S; Garcia-Areas R; Guthrie K; Torroella-Kouri M; Iragavarapu-Charyulu V
Cell Immunol; 2011; 270(2):172-82. PubMed ID: 21621198
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.
Bonecchi R; Polentarutti N; Luini W; Borsatti A; Bernasconi S; Locati M; Power C; Proudfoot A; Wells TN; Mackay C; Mantovani A; Sozzani S
J Immunol; 1999 Jan; 162(1):474-9. PubMed ID: 9886422
[TBL] [Abstract][Full Text] [Related]
31. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
[TBL] [Abstract][Full Text] [Related]
32. Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.
Municio C; Criado G
Front Immunol; 2020; 11():631743. PubMed ID: 33569065
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of chemokine receptors CCR1 and CCR3 in nasal polyps: molecular basis for recruitment of the granulocyte infiltrate.
Fundová P; Funda DP; Kovář D; Holý R; Navara M; Tlaskalová-Hogenová H
Folia Microbiol (Praha); 2013 May; 58(3):219-24. PubMed ID: 23054685
[TBL] [Abstract][Full Text] [Related]
34. CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.
Errahali YJ; Taka E; Abonyo BO; Heiman AS
J Interferon Cytokine Res; 2009 Apr; 29(4):227-39. PubMed ID: 19203252
[TBL] [Abstract][Full Text] [Related]
35. [Advances in the study of small molecule antagonists of chemokine receptors as anti-asthma agents].
Ji HJ; Hu JF; Chen NH
Yao Xue Xue Bao; 2011 Nov; 46(11):1286-90. PubMed ID: 22260017
[TBL] [Abstract][Full Text] [Related]
36. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding.
Crown SE; Yu Y; Sweeney MD; Leary JA; Handel TM
J Biol Chem; 2006 Sep; 281(35):25438-46. PubMed ID: 16803905
[TBL] [Abstract][Full Text] [Related]
37. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
38. Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
França CN; Izar MCO; Hortêncio MNS; do Amaral JB; Ferreira CES; Tuleta ID; Fonseca FAH
Clin Sci (Lond); 2017 Jun; 131(12):1215-1224. PubMed ID: 28566450
[TBL] [Abstract][Full Text] [Related]
39. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B.
Berkhout TA; Sarau HM; Moores K; White JR; Elshourbagy N; Appelbaum E; Reape RJ; Brawner M; Makwana J; Foley JJ; Schmidt DB; Imburgia C; McNulty D; Matthews J; O'Donnell K; O'Shannessy D; Scott M; Groot PH; Macphee C
J Biol Chem; 1997 Jun; 272(26):16404-13. PubMed ID: 9195948
[TBL] [Abstract][Full Text] [Related]
40. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
